Tags

Type your tag names separated by a space and hit enter

New antiepileptic drugs.
Arch Neurol. 1998 Sep; 55(9):1181-3.AN

Abstract

The current developments in the availability of new antiepileptic drugs (AEDs) are unprecedented. After a period of many years during which no new AED became available, 5 new AEDs were introduced in the United States between 1993 and 1997, and 2 more are expected to be approved soon. These new drugs are a most welcome addition to the therapeutic options in the treatment of epilepsy, but they also create a dilemma for the clinician because their individual places and their optimal use in the treatment of various forms of epilepsy are yet to be determined. This review serves to summarize the main characteristics of the newer AEDs.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Bourgeois BF
Washington University School of Medicine, St. Louis, MO, USA.

MeSH

AcetatesAminesAnticonvulsantsCarbamazepineCyclohexanecarboxylic AcidsDrug ApprovalEpilepsyFelbamateFructoseGabapentinHumansLamotrigineNipecotic AcidsOxcarbazepinePhenylcarbamatesPropylene GlycolsTiagabineTopiramateTriazinesUnited StatesVigabatringamma-Aminobutyric Acid

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

9740111

Citation

Bourgeois, B F.. "New Antiepileptic Drugs." Archives of Neurology, vol. 55, no. 9, 1998, pp. 1181-3.
Bourgeois BF. New antiepileptic drugs. Arch Neurol. 1998;55(9):1181-3.
Bourgeois, B. F. (1998). New antiepileptic drugs. Archives of Neurology, 55(9), 1181-3.
Bourgeois BF. New Antiepileptic Drugs. Arch Neurol. 1998;55(9):1181-3. PubMed PMID: 9740111.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - New antiepileptic drugs. A1 - Bourgeois,B F, PY - 1998/9/18/pubmed PY - 2000/2/19/medline PY - 1998/9/18/entrez SP - 1181 EP - 3 JF - Archives of neurology JO - Arch Neurol VL - 55 IS - 9 N2 - The current developments in the availability of new antiepileptic drugs (AEDs) are unprecedented. After a period of many years during which no new AED became available, 5 new AEDs were introduced in the United States between 1993 and 1997, and 2 more are expected to be approved soon. These new drugs are a most welcome addition to the therapeutic options in the treatment of epilepsy, but they also create a dilemma for the clinician because their individual places and their optimal use in the treatment of various forms of epilepsy are yet to be determined. This review serves to summarize the main characteristics of the newer AEDs. SN - 0003-9942 UR - https://www.unboundmedicine.com/medline/citation/9740111/New_antiepileptic_drugs_ L2 - https://jamanetwork.com/journals/jamaneurology/fullarticle/vol/55/pg/1181 DB - PRIME DP - Unbound Medicine ER -